| Literature DB >> 34911584 |
Amaury Ábrego-Gacía1,2, Héctor M Poggi-Varaldo3,4, Vania Robles-González5, Teresa Ponce-Noyola1, Graciano Calva-Calva1, Elvira Ríos-Leal1, Daniel Estrada-Bárcenas6, Alfredo Mendoza-Vargas7.
Abstract
Methane from enteric fermentation is the gas with the greatest environmental impact emitted by ruminants. Lovastatin (Lv) addition to feedstocks could be a strategy to mitigate rumen methane emissions via decreasing the population of methanogenic archaea (MA). Thus, this paper provides the first overview of the effects of Lv supplementation, focusing on the inhibition of methane production, rumen microbiota, and ruminal fermentation. Results indicated that Lv treatment had a strong anti-methanogenic effect on pure strains of MA. However, there are uncertainties from in vitro rumen fermentation trials with complex substrates and rumen inoculum.Solid-state fermentation (SSF) has emerged as a cost-effective option to produce Lv. In this way, SSF of agricultural residues as an Lv-carrier supplement in sheep and goats demonstrated a consistent decrease in ruminal methane emissions. The experimental evidence for in vitro conditions showed that Lv did not affect the volatile fatty acids (VFA). However, in vivo experiments demonstrated that the production of VFA was decreased. Lv did not negatively affect the digestibility of dry matter during in vitro and in vivo methods, and there is even evidence that it can induce an increase in digestibility. Regarding the rumen microbiota, populations of MA were reduced, and no differences were detected in alpha and beta diversity associated with Lv treatment. However, some changes in the relative abundance of the microbiota were induced. Further studies are recommended on: (i) Lv biodegradation products and stability, as well as its adsorption onto the solid matter in the rumen, to gain more insight on the "available" or effective Lv concentration; and (ii) to determine whether the effect of Lv on ruminal fermentation also depends on the feed composition and different ruminants.Entities:
Keywords: Fermentation; Lovastatin; Methanogenesis; Microbiota; Rumen
Year: 2021 PMID: 34911584 PMCID: PMC8675506 DOI: 10.1186/s40104-021-00641-8
Source DB: PubMed Journal: J Anim Sci Biotechnol ISSN: 1674-9782
Fig. 1Biosynthesis of archaea membrane ether lipids. a Mevalonate pathway and archaeal lipid synthesis. b Inhibitory effect of the lovastatin on HMG-CoA reductase, the rate-limiting enzyme in the conversion of HMG-CoA to Mevalonate [12, 17]
Effect of lovastatin on in vitro ruminal methane production
| Source of Lv | Donor animals and experimental diet | Lv, mg/L | Methane | Reference | |
|---|---|---|---|---|---|
| Sigma-Aldrich, St Louis, MO, USA | Technique: Hungate tubes Culture medium: BRN Inoculum: | 4 | 99 | [ | |
| Fermented rice straw extracts | Technique: serum bottles Culture medium: Balch 1 (DSMZ, Germany) Inoculum: | 50 | 100 | [ | |
| Sigma-Aldrich, St Louis, MO, USA | Technique: Hungate tubes Culture medium: SAB Inoculum: | 4 | 100 | [ | |
| Sigma-Aldrich, St Louis, MO, USA | Ruminant: bovine Diet: f:ca ratio of (50:50) | Technique: fermentation bottles Substrate: diet with a f:c ratio of (50:50) Inoculum: ruminal fluid | 5 | NSb | [ |
| Sigma-Aldrich, GmbH, Buchs, Switzerland | Ruminant: bovine Diet: hay, ryegrass, and concentrate | Technique: RUSITEC system Substrate: diet with a f:c ratio of (50:50) Inoculum: ruminal fluid | 150 | 40 | [ |
| Fermented rice straw | Ruminant: bovine Diet: f:c ratio of (40:60) | Technique: calibrated glass syringes Substrate: fermented rice straw Inoculum: ruminal fluid | 4.3 | 24 | [ |
| Sigma-Aldrich, St Louis, MO, USA | Ruminant: bovine Diet: f:c ratio of (60:40) | Technique: serum bottles Substrate: diet with a f:c ratio of (50:50) Inoculum: ruminal fluid | 3.2 | NS | [ |
| Fermented rice | Ruminant: sheep Diet: hay | Technique: Hungate tubes Substrate: fermented rice Inoculum: ruminal fluid | 40 | 9.6 | [ |
Fermented purple corn stover | Ruminant: dairy steers Diet: no reported | Technique: serum bottles Substrate: fermented purple corn cob Inoculum: ruminal fluid | 29.5 | 14.6 | [ |
Fermented Oat straw | Ruminant: bovine Diet: f:c ratio of (60:40) | Technique: serum bottles Substrate: diet with a f:c ratio of (30:70) Inoculum: ruminal fluid | 150 | 38 | [ |
| Simvastatin, Sigma-Aldrich, Prague, Czech Republic | Ruminant: bovine Diet: f:c ratio of (70:30) | Technique: serum bottles Substrate: diet with a f:c ratio of (64:36) Inoculum: ruminal fluid | 100 | 26.2 | [ |
aForage: concentrate ratio
bNon-significant
Effect of lovastatin on in vivo ruminal methane emissions
| Source of Lv | Animal and experimental diet | Technique to estimate rumen CH4 | Lv, mg/kg LWb | Methane production, g CH4/Kg DMIa | Reference | |
|---|---|---|---|---|---|---|
| Control | Treatment | |||||
| Commercial Lv (98% purity, Yick-Vic Chemicals & Pharmaceuticals Ltd., Hong Kong, China) | Ruminant: Sheep Diet: f:cc ratio of (45:52) | Open-circuit respiratory chamber | 1.06 | 25.1 | 25.9 | [ |
| Fermented red rice power (Zhejiang Medicines and Health Products, Hangzhou, China) | Ruminant: Bovine Diet: f:c ratio of (15:85) | Open-circuit respiratory chamber | 0.92 | 20 | 17.1 | [ |
| Fermented rice | Ruminant: Sheep Diet: Based on rice (50%) and rice hay (50%) | Sulfur hexafluoride (SF6) | 2.26 | 35.2 | 24.9 | [ |
| Red yeast rice | Ruminant: Goats Diet: f:c ratio of (70:30) | Open-circuit respiratory chamber | 4.34 | 20 | 18.3 | [ |
| Fermented rice straw | Ruminant: Goats Diet f:c ratio of (40:60) | Open-circuit respiratory chamber | 4.14 | 60 | 35 | [ |
| Fermented palm kernel cake | Ruminant: Goats Diet: f:c ratio of (73:27) | Open-circuit respiratory chamber | 6 | 24.23 | 19.23 | [ |
aDry matter intake
bLive weight
cForage:concentrate ratio
Effects of lovastatin on rumen fermentation variables
| pH | NH3-N | Total VFA | Acetate | Propionate | Butyrate | A:Pa | Digestibility | Reference |
|---|---|---|---|---|---|---|---|---|
| ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | [ |
| ≈ | ↓ | ≈ | ↑ | ↓ | ≈ | NRb | ≈ | [ |
| ↑ | NR | ≈ | ≈ | ↓ | ≈ | ≈ | ↑ | [ |
| ≈ | NR | ≈ | ≈ | ≈ | ≈ | NR | ≈ | [ |
| NR | NR | ≈ | ↓ | ≈ | ≈ | ≈ | ≈ | [ |
| ≈ | ↑ | ≈ | ↓ | ↑ | ≈ | NR | ↑ | [ |
| ≈ | NR | ↓ | ↓ | ↑ | ≈ | ↓ | NR | [ |
| ≈ | ≈ | ↓ | ↓ | ↑ | ↓ | ↓ | ≈ | [ |
| ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | ≈ | [ |
| NR | NR | ↓ | ≈ | ≈ | ≈ | ≈ | NR | [ |
| NR | NR | ↓ | ↓ | ≈ | ≈ | ↓ | NR | [ |
| NR | ≈ | ≈ | ≈ | ≈ | ≈ | ↓ | ≈ | [ |
| NR | NR | ≈ | ≈ | ↑ | ↑ | ↑ | ↑ | [ |
| ≈ | NR | ≈ | ≈ | ↑ | ≈ | ↓ | ≈ | [ |
aAcetic to propionic acid ratio
bNR, Not reported; ↓, decreased; ↑, increased; ≈ unchanged
Fig. 2Hydrolysis of lovastatin lactone and the similarity between the chemical structures of lovastatin β-hydroxy acid and the HMG-CoA. a Lovastatin lactone, b Lovastatin β-hydroxy acid, c HMGCoA, and d Mevalonate. Adapted from Syed and Ponnisamy [53]